Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients

被引:7
|
作者
Katakami, Naoto [1 ]
Kaneto, Hideaki [1 ]
Matsuhisa, Munehide [2 ]
Shimomura, Iichiro [1 ]
Yamasaki, Yoshimitsu [3 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan
[2] Univ Tokushima, Diabet Therapeut & Res Ctr, Tokushima, Japan
[3] Osaka Univ, Ctr Adv Sci & Innovat, Suita, Osaka 565, Japan
关键词
IMT; Carotid atherosclerosis; Glimepiride; Glibenclamide; INTIMA-MEDIA THICKNESS; ARTERY-DISEASE; RISK;
D O I
10.1016/j.diabres.2010.12.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We performed a 3-year observation study of type 2 diabetic patients treated with glibenclamide or glimepiride and found that the annual progression of the maximum carotid intima-media thickness was significantly attenuated in the subjects treated with glimepiride (n = 20) as compared with those treated with glibenclamide (n = 20) (-0.044 +/- 0.171 mm/year vs. 0.077 +/- 0.203 mm/year, p = 0.0474). (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E20 / E22
页数:3
相关论文
共 50 条
  • [41] Clinical significance of hepatocyte growth factor for diabetic complications, including carotid atherosclerosis in Type 2 diabetic patients.
    Konya, H
    Hamaguchi, T
    Satani, K
    Umehara, A
    Ishikawa, T
    Kohri, K
    Hasegawa, Y
    Suehiro, A
    Kakishita, E
    Namba, M
    DIABETOLOGIA, 2003, 46 : A373 - A374
  • [42] Relationships between Echocardiographic Findings, Pulse Wave Velocity, and Carotid Atherosclerosis in Type 2 Diabetic Patients
    Hisashi Masugata
    Shoichi Senda
    Kay Yoshikawa
    Yumiko Yoshihara
    Hiroyuki Daikuhara
    Yoshihide Ayada
    Hirofumi Matsushita
    Hiroyuki Nakamura
    Teruhisa Taoka
    Masakazu Kohno
    Hypertension Research, 2005, 28 : 965 - 971
  • [43] Relationships between echocardiographic findings, pulse wave velocity, and carotid atherosclerosis in type 2 diabetic patients
    Masugata, H
    Senda, S
    Yoshikawa, K
    Yoshihara, Y
    Daikuhara, H
    Ayada, Y
    Matsushita, H
    Nakamura, H
    Kohno, M
    HYPERTENSION RESEARCH, 2005, 28 (12) : 965 - 971
  • [44] Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients
    Miwa, S
    Inouye, M
    Ohmura, C
    Mitsuhashi, N
    Onuma, T
    Kawamori, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (02) : 81 - 88
  • [45] Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients
    Matsumoto, K.
    Yano, Y.
    Gabazza, E. C.
    Araki, R.
    Bruno, N. E.
    Suematsu, M.
    Akatsuka, H.
    Katsuki, A.
    Taguchi, O.
    Adachi, Y.
    Sumida, Y.
    DIABETIC MEDICINE, 2007, 24 (12) : 1322 - 1328
  • [46] The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus
    Michiaki Miyamoto
    Kazuhiko Kotani
    Kenta Okada
    Yasutomo Fujii
    Kei Konno
    Shun Ishibashi
    Nobuyuki Taniguchi
    Acta Diabetologica, 2012, 49 : 63 - 68
  • [47] Serum Laminin level is associated with plaque progression in carotid atherosclerosis of Type 2 diabetic patients.
    Park, TSS
    Park, JH
    Baek, HS
    DIABETOLOGIA, 2003, 46 : A372 - A373
  • [48] Inverse correlation between activated protein C generation and carotid atherosclerosis in type 2 diabetic patients
    Matsumoto, K.
    Yano, Y.
    Araki, R.
    Suematsu-Urawa, M.
    Akatsuka, H.
    Suzuki, T.
    Sasaki, Y.
    Bruno, N. E.
    Katsuki, A.
    Gabazza, E. C.
    Sumida, Y.
    DIABETOLOGIA, 2007, 50 : S104 - S104
  • [49] The non-HDL cholesterol risk factor for carotid atherosclerosis in type 2 diabetic patients in Tunisia
    Ben Ahmed, I.
    Ben Dahmen, F.
    Ben Amor, A.
    Bouzaidi, K.
    Narjess, K.
    Jamoussi, H.
    Azzabi, S.
    Chabchoub, S.
    DIABETES & METABOLISM, 2011, 37 : A40 - A40
  • [50] Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids
    Taniguchi, A
    Nakai, Y
    Fukushima, M
    Teramura, S
    Hayashi, R
    Hama, K
    Marumoto, K
    Watanabe, T
    Yoshioka, I
    Sakaguchi, K
    Kishimoto, H
    Matsushita, K
    Okumura, T
    Tokuyama, K
    Nagasaka, S
    Sakai, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (05): : 539 - 543